-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDICUS PHARMA REPORTS KOL VALIDATION OF SKINJECT PHASE 2 DATA OF 80% OVERALL RESPONSE RATE

Reuters·03/30/2026 11:30:01

Please log in to view news